Truist Financial Reiterates Buy Rating for UnitedHealth Group (NYSE:UNH)

Truist Financial reissued their buy rating on shares of UnitedHealth Group (NYSE:UNH - Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $600.00 price target on the healthcare conglomerate's stock.

UNH has been the topic of a number of other reports. Barclays began coverage on shares of UnitedHealth Group in a research report on Wednesday, March 6th. They set an overweight rating and a $551.00 target price on the stock. Erste Group Bank restated a hold rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Oppenheimer reaffirmed an outperform rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Royal Bank of Canada reaffirmed an outperform rating and issued a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Finally, HSBC raised UnitedHealth Group from a reduce rating to a hold rating and set a $460.00 price target for the company in a research note on Thursday, April 4th. Three analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of Moderate Buy and a consensus price target of $571.20.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $10.10 on Wednesday, hitting $478.99. The stock had a trading volume of 8,753,188 shares, compared to its average volume of 4,466,714. UnitedHealth Group has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The firm's 50 day moving average price is $490.31 and its 200-day moving average price is $515.63. The company has a market capitalization of $441.60 billion, a price-to-earnings ratio of 20.09, a price-to-earnings-growth ratio of 1.22 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm's quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.26 EPS. On average, equities research analysts predict that UnitedHealth Group will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group's dividend payout ratio is 31.54%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of UNH. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Robbins Farley acquired a new position in UnitedHealth Group during the third quarter worth about $25,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 50 shares in the last quarter. True Wealth Design LLC acquired a new position in UnitedHealth Group during the fourth quarter worth about $31,000. Finally, NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock worth $33,000 after purchasing an additional 51 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.